| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.027 | 0.5 |